End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.73 CNY | +1.05% | +2.93% | +29.48% |
Apr. 26 | Bank of Shanghai Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 29 | Beijing Tong Ren Tang Chinese Medicine CEO Steps Down; Acting CEO Appointed | MT |
Strengths
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company appears to be poorly valued given its net asset value.
- This company will be of major interest to investors in search of a high dividend stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Banks
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+29.48% | 15.18B | B- | ||
+26.25% | 210B | C+ | ||
-0.27% | 72.35B | A- | ||
+10.42% | 56.71B | C+ | ||
+23.09% | 51.8B | B- | ||
+11.23% | 51.77B | B- | ||
+36.41% | 47.09B | B | ||
+3.62% | 34.71B | B- | ||
-16.21% | 35.14B | A- | ||
-96.60% | 32.24B | - | D |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 601229 Stock
- Ratings Bank of Shanghai Co., Ltd.